These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15205592

  • 1. 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Escaned J, Moreno R, Hernández-Antolin R, Sabaté M, Trabetti E, Pignatti PF, Macaya C.
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):427-33. PubMed ID: 15205592
    [Abstract] [Full Text] [Related]

  • 2. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.
    Am J Cardiol; 2005 Oct 15; 96(8):1095-9. PubMed ID: 16214444
    [Abstract] [Full Text] [Related]

  • 3. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Sabaté M, Fernández C, Stranieri C, Trabetti E, Pignatti PF, Macaya C.
    Blood Coagul Fibrinolysis; 2004 Jan 15; 15(1):89-93. PubMed ID: 15166949
    [Abstract] [Full Text] [Related]

  • 4. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Hernández-Antolín R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Macaya C.
    J Invasive Cardiol; 2004 Jun 15; 16(6):325-9. PubMed ID: 15156004
    [Abstract] [Full Text] [Related]

  • 5. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.
    Thromb Res; 2005 Jun 15; 116(6):491-7. PubMed ID: 16181985
    [Abstract] [Full Text] [Related]

  • 6. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Barrera-Ramirez C, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.
    Thromb Res; 2005 Jun 15; 115(1-2):101-8. PubMed ID: 15567460
    [Abstract] [Full Text] [Related]

  • 7. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany VL, Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Am Heart J; 2003 Feb 15; 145(2):239-47. PubMed ID: 12595840
    [Abstract] [Full Text] [Related]

  • 8. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
    von Beckerath N, von Beckerath O, Koch W, Eichinger M, Schömig A, Kastrati A.
    Blood Coagul Fibrinolysis; 2005 Apr 15; 16(3):199-204. PubMed ID: 15795539
    [Abstract] [Full Text] [Related]

  • 9. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ, Bernardo E, Palazuelos J, Desai B, Weisberg I, Alfonso F, Guzman LA, Hernández-Antolin R, Zenni MZ, Macaya C, Fernandez-Ortiz A, Bass TA.
    Thromb Haemost; 2008 Jan 15; 99(1):161-8. PubMed ID: 18217149
    [Abstract] [Full Text] [Related]

  • 10. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.
    Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn HP, Büttner HJ, Neumann FJ.
    J Am Coll Cardiol; 2010 Jun 01; 55(22):2427-34. PubMed ID: 20510210
    [Abstract] [Full Text] [Related]

  • 11. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
    Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D.
    JAMA; 2011 Sep 21; 306(11):1215-23. PubMed ID: 21934054
    [Abstract] [Full Text] [Related]

  • 12. Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.
    Gladding P, White H, Voss J, Ormiston J, Stewart J, Ruygrok P, Bvaldivia B, Baak R, White C, Webster M.
    JACC Cardiovasc Interv; 2009 Nov 21; 2(11):1095-101. PubMed ID: 19926050
    [Abstract] [Full Text] [Related]

  • 13. Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.
    Giusti B, Gori AM, Marcucci R, Sestini I, Saracini C, Paniccia R, Poli S, Giglioli C, Valente S, Prisco D, Gensini GF, Abbate R.
    Atherosclerosis; 2008 Jan 21; 196(1):341-348. PubMed ID: 17157856
    [Abstract] [Full Text] [Related]

  • 14. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML.
    JACC Cardiovasc Interv; 2008 Dec 21; 1(6):620-7. PubMed ID: 19463375
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M, Daffara V, Pergolini P, Rolla R, Marino P, Bellomo G, Carriero A, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Vascul Pharmacol; 2017 Aug 21; 93-95():42-47. PubMed ID: 28433569
    [Abstract] [Full Text] [Related]

  • 16. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Romero-Barra M, Camoin L, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC.
    Thromb Haemost; 2007 Feb 21; 97(2):212-7. PubMed ID: 17264949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?
    Angiolillo DJ, Fernández-Ortiz A, Bernardo E, Barrera Ramírez C, Sabaté M, Fernandez C, Hernández-Antolín R, Escaned J, Alfonso F, Macaya C.
    J Invasive Cardiol; 2004 Apr 21; 16(4):169-74. PubMed ID: 15152138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiplatelet effect of 50-mg maintenance dose of clopidogrel compared to 200 mg ticlopidine: a preliminary study.
    Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Kuwabara Y, Nomura F, Komuro I.
    Heart Vessels; 2010 Jan 21; 25(1):41-4. PubMed ID: 20091397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.